Patents by Inventor Stephen Marc Bowen

Stephen Marc Bowen has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • IMIDAZOPYRIDINE ANALOGS AND THEIR USE AS AGONISTS OF THE WNT-BETA-CATENIN CELLULAR MESSAGING SYSTEM
    Publication number: 20090069319
    Abstract: The present invention relates to imidazopyridine analogs, methods of making imidazopyridine analogs, compositions comprising an imidazopyridine analog, and methods for treating canonical Wnt-?-catenin cellular messaging system-related disorders comprising administering to a subject in need thereof an effective amount of an imidazopyridine analog.
    Type: Application
    Filed: August 26, 2008
    Publication date: March 12, 2009
    Applicant: Wyeth
    Inventors: Joseph Theodore Lundquist, IV, Stephen Marc Bowen, John Francis Mehlmann, Jeffrey Claude Pelletier, Matthew Douglas Vera
  • (Hydroxyphenyl)-1H-indole-3-carbaldehyde oxime derivatives as estrogenic agents
    Patent number: 7250440
    Abstract: This invention provides estrogen receptor modulators of formula I, having the structure where R1, R2, R3, and R4 are as defined in the specification, or a pharmaceutically acceptable salt thereof.
    Type: Grant
    Filed: August 9, 2004
    Date of Patent: July 31, 2007
    Assignee: Wyeth
    Inventors: Richard Eric Mewshaw, Stephen Marc Bowen, Eric Steven Manas